Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2022

01-04-2022 | Acute Kidney Injury | Original Article

Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis

Authors: Nadim Mahmud, Sumeet K. Asrani, Peter P. Reese, David E. Kaplan, Tamar H. Taddei, Mitra K. Nadim, Marina Serper

Published in: Digestive Diseases and Sciences | Issue 4/2022

Login to get access

Abstract

Background

Accuracy of glomerular filtration rate estimating (eGFR) equations has significant implications in cirrhosis, potentially guiding simultaneous liver kidney allocation and drug dosing. Most equations adjust for Black race, partially accounted for by reported differences in muscle mass by race. Patients with cirrhosis, however, are prone to sarcopenia which may mitigate such differences. We evaluated the association between baseline eGFR and incident acute kidney injury (AKI) in patients with cirrhosis with and without race adjustment.

Methods

We conducted a retrospective national cohort study of veterans with cirrhosis. Baseline eGFR was calculated using multiple eGFR equations including Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), both with and without race adjustment. Poisson regression was used to investigate the association between baseline eGFR and incident AKI events per International Club of Ascites criteria.

Results

We identified 72,267 patients with cirrhosis, who were 97.3% male, 57.8% white, and 19.7% Black. Over median follow-up 2.78 years (interquartile range 1.22–5.16), lower baseline eGFR by CKD-EPI was significantly associated with higher rates of AKI in adjusted models. For all equations this association was minimally impacted when race adjustment was removed. For example, removal of race adjustment from CKD-EPI resulted in a 0.1% increase in the association between lower eGFR and higher rate of AKI events per 15 mL/min/1.73 m2 change (p < 0.001).

Conclusions

Race adjustment in eGFR equations did not enhance AKI risk estimation in patients with cirrhosis. Further study is warranted to assess the impacts of removing race from eGFR equations on clinical outcomes and policy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yudell M, Roberts D, DeSalle R, Tishkoff S. Taking race out of human genetics. Science 2016;351:564–565CrossRef Yudell M, Roberts D, DeSalle R, Tishkoff S. Taking race out of human genetics. Science 2016;351:564–565CrossRef
2.
go back to reference Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA 2019;322:113–4CrossRef Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA 2019;322:113–4CrossRef
3.
go back to reference Vyas DA, Eisenstein LG, Jones DS. Hidden in plain sight—reconsidering the use of race correction in clinical algorithms. Mass Med Soc; 2020. Vyas DA, Eisenstein LG, Jones DS. Hidden in plain sight—reconsidering the use of race correction in clinical algorithms. Mass Med Soc; 2020.
5.
go back to reference Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, Magder LS. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology 2014;59:1532–1542CrossRef Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, Magder LS. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology 2014;59:1532–1542CrossRef
6.
go back to reference Francoz C, Nadim MK, Baron A et al. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology 2014;59:1514–1521CrossRef Francoz C, Nadim MK, Baron A et al. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology 2014;59:1514–1521CrossRef
7.
go back to reference De Souza V, Hadj-Aissa A, Dolomanova O et al. Creatinine-versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis. Hepatology 2014;59:1522–1531CrossRef De Souza V, Hadj-Aissa A, Dolomanova O et al. Creatinine-versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis. Hepatology 2014;59:1522–1531CrossRef
8.
go back to reference Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004;10:301–309CrossRef Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004;10:301–309CrossRef
9.
go back to reference Francoz C, Prie D, Abdelrazek W et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010;16:1169–1177CrossRef Francoz C, Prie D, Abdelrazek W et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010;16:1169–1177CrossRef
10.
go back to reference Asrani SK, Jennings LW, Trotter JF et al. A model for glomerular filtration rate assessment in liver disease (GRAIL) in the presence of renal dysfunction. Hepatology 2019;69:1219–1230CrossRef Asrani SK, Jennings LW, Trotter JF et al. A model for glomerular filtration rate assessment in liver disease (GRAIL) in the presence of renal dysfunction. Hepatology 2019;69:1219–1230CrossRef
11.
go back to reference Cohn S, Abesamis C, Zanzi I, Aloia J, Yasumura S, Ellis K. Body elemental composition: comparison between black and white adults. Am J Physiol Endocrinol Metab 1977;232:E419CrossRef Cohn S, Abesamis C, Zanzi I, Aloia J, Yasumura S, Ellis K. Body elemental composition: comparison between black and white adults. Am J Physiol Endocrinol Metab 1977;232:E419CrossRef
12.
go back to reference Yoo J-J, Kim SG, Kim YS et al. Estimation of renal function in patients with liver cirrhosis: impact of muscle mass and sex. J Hepatol 2019;70:847–854CrossRef Yoo J-J, Kim SG, Kim YS et al. Estimation of renal function in patients with liver cirrhosis: impact of muscle mass and sex. J Hepatol 2019;70:847–854CrossRef
13.
go back to reference Carey EJ, Lai JC, Wang CW et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transplant 2017;23:625–633CrossRef Carey EJ, Lai JC, Wang CW et al. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transplant 2017;23:625–633CrossRef
14.
go back to reference Tonon M, Rosi S, Gambino CG, et al. Natural history of acute kidney disease in patients with cirrhosis. J Hepatol 2020. Tonon M, Rosi S, Gambino CG, et al. Natural history of acute kidney disease in patients with cirrhosis. J Hepatol 2020.
15.
go back to reference Maiwall R, Pasupuleti SSR, Bihari C et al. Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study. Hepatology 2020;71:1009–1022CrossRef Maiwall R, Pasupuleti SSR, Bihari C et al. Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study. Hepatology 2020;71:1009–1022CrossRef
16.
go back to reference Tandon P, James MT, Abraldes JG, Karvellas CJ, Ye F, Pannu N. Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study. PLoS One 2016;11:e0160394CrossRef Tandon P, James MT, Abraldes JG, Karvellas CJ, Ye F, Pannu N. Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study. PLoS One 2016;11:e0160394CrossRef
17.
go back to reference Kaplan DE, Dai F, Aytaman A et al. Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database. Clin Gastroenterol Hepatol 2015;13:2333–41.e6.CrossRef Kaplan DE, Dai F, Aytaman A et al. Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database. Clin Gastroenterol Hepatol 2015;13:2333–41.e6.CrossRef
18.
go back to reference Goldberg D, Lewis J, Halpern S, Weiner M, Lo Re III V. Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative database. Pharmacoepidemiol Drug Saf 2012;21:765–9. Goldberg D, Lewis J, Halpern S, Weiner M, Lo Re III V. Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative database. Pharmacoepidemiol Drug Saf 2012;21:765–9.
19.
go back to reference Rebholz CM, Coresh J, Ballew SH et al. Kidney failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) study: comparing ascertainment of treated and untreated kidney failure in a cohort study. Am J Kidney Dis 2015;66:231–239CrossRef Rebholz CM, Coresh J, Ballew SH et al. Kidney failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) study: comparing ascertainment of treated and untreated kidney failure in a cohort study. Am J Kidney Dis 2015;66:231–239CrossRef
20.
go back to reference Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology 2015;149:1471–82.e5CrossRef Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology 2015;149:1471–82.e5CrossRef
21.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Internal Med 1999;130:461–470CrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Internal Med 1999;130:461–470CrossRef
22.
go back to reference Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Internal Med 2009;150:604–612CrossRef Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Internal Med 2009;150:604–612CrossRef
23.
go back to reference Angeli P, Ginès P, Wong F et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015;64:531–537CrossRef Angeli P, Ginès P, Wong F et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 2015;64:531–537CrossRef
24.
go back to reference Hsieh YC, Lee KC, Chen PH, Su CW, Hou MC, Lin HC. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding. J Gastroenterol Hepatol 2017;32:1859–1866CrossRef Hsieh YC, Lee KC, Chen PH, Su CW, Hou MC, Lin HC. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding. J Gastroenterol Hepatol 2017;32:1859–1866CrossRef
25.
go back to reference Sohn W, Kim JH, Cho JY. Effect of acute kidney injury on long-term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria. J Gastroenterol Hepatol 2020;35:870–876CrossRef Sohn W, Kim JH, Cho JY. Effect of acute kidney injury on long-term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria. J Gastroenterol Hepatol 2020;35:870–876CrossRef
26.
go back to reference Xiong J, Pu L, Xiong H et al. Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU. Scand J Gastroenterol 2018;53:1590–1596CrossRef Xiong J, Pu L, Xiong H et al. Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU. Scand J Gastroenterol 2018;53:1590–1596CrossRef
27.
go back to reference Durand F, Francoz C, Asrani SK et al. Acute kidney injury after liver transplantation. Transplantation 2018;102:1636–1649CrossRef Durand F, Francoz C, Asrani SK et al. Acute kidney injury after liver transplantation. Transplantation 2018;102:1636–1649CrossRef
28.
go back to reference Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol 2019;71:811–822CrossRef Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol 2019;71:811–822CrossRef
29.
go back to reference Dominitz JA, Maynard C, Boyko EJ. Assessment of vital status in Department of Veterans Affairs national databases: comparison with state death certificates. Ann Epidemiol 2001;11:286–291CrossRef Dominitz JA, Maynard C, Boyko EJ. Assessment of vital status in Department of Veterans Affairs national databases: comparison with state death certificates. Ann Epidemiol 2001;11:286–291CrossRef
30.
go back to reference Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361:1279–1290CrossRef Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361:1279–1290CrossRef
31.
go back to reference Wong F, Jepsen P, Watson H, Vilstrup H. Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites. Liver Int 2018;38:1785–1792CrossRef Wong F, Jepsen P, Watson H, Vilstrup H. Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites. Liver Int 2018;38:1785–1792CrossRef
32.
go back to reference Gallagher D, Visser M, De Meersman RE et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 1997;83:229–239CrossRef Gallagher D, Visser M, De Meersman RE et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 1997;83:229–239CrossRef
33.
go back to reference Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003;41:269–278CrossRef Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003;41:269–278CrossRef
34.
go back to reference Daugherty N, Hammond K, Osberg I. Bilirubin interference with the kinetic Jaffé method for serum creatinine. Clin Chem 1978;24:392–393CrossRef Daugherty N, Hammond K, Osberg I. Bilirubin interference with the kinetic Jaffé method for serum creatinine. Clin Chem 1978;24:392–393CrossRef
35.
go back to reference Mindikoglu AL, Regev A, Seliger SL, Magder LS. Gender disparity in liver transplant waiting-list mortality: The importance of kidney function. Liver Transplant 2010;16:1147–1157CrossRef Mindikoglu AL, Regev A, Seliger SL, Magder LS. Gender disparity in liver transplant waiting-list mortality: The importance of kidney function. Liver Transplant 2010;16:1147–1157CrossRef
36.
go back to reference Cholongitas E, Marelli L, Kerry A et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13:523–529CrossRef Cholongitas E, Marelli L, Kerry A et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13:523–529CrossRef
37.
go back to reference Kalafateli M, Wickham F, Burniston M et al. Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: the royal free hospital cirrhosis glomerular filtration rate. Hepatology 2017;65:582–591CrossRef Kalafateli M, Wickham F, Burniston M et al. Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: the royal free hospital cirrhosis glomerular filtration rate. Hepatology 2017;65:582–591CrossRef
Metadata
Title
Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis
Authors
Nadim Mahmud
Sumeet K. Asrani
Peter P. Reese
David E. Kaplan
Tamar H. Taddei
Mitra K. Nadim
Marina Serper
Publication date
01-04-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06943-1

Other articles of this Issue 4/2022

Digestive Diseases and Sciences 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.